Cytokine storm intervention in the early stages of COVID-19 pneumonia-Reference-Cited by-同舟云学术

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Published:2020-06 Issue: Volume:53 Page:38-42
ISSN:1359-6101
Container-title:Cytokine & Growth Factor Reviews
language:en
Short-container-title:Cytokine & Growth Factor Reviews

Author:

Sun Xinjuan,Wang Tianyuan,Cai Dayong,Hu Zhiwei,Chen Jin’an,Liao Hui,Zhi Liming,Wei Hongxia,Zhang Zhihong,Qiu Yuying,Wang Jing,Wang Aiping

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study;Wu;Lancet,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

3. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version);Jin;Mil. Med. Res.,2020

4. Cytokine release syndrome;Shimabukuro-Vornhagen;J. Immunother. Cancer,2018

5. Immunotherapeutic implications of IL-6 blockade for cytokine storm;Tanaka;Immunotherapy,2016

Cited by 374 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-6 is a predictor and potential therapeutic target for coronavirus disease 2019-related heart failure: A single-center retrospective study;Cytokine;2024-04

2. Role of IL-6 as ‘core inflammatory marker’ in assessment of severity, response to therapy and predicting outcome in COVID-19 pneumonia: A single center experience of 2400 cases in tertiary care setting in India;Sri Ramachandra Journal of Health Sciences;2024-01-04

3. Focusing on the cytokine storm in the battle against COVID-19: the rising role of mesenchymal-derived stem cells;Stem Cells;2024

4. Estimating Time Window to Administer Anti-Cytokine Therapeutic Drugs to COVID-19 Patients;IEEE Transactions on NanoBioscience;2024-01

5. Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis;Inflammopharmacology;2023-12-14